Bevacizumab 1 recalled over sterility concerns
- Recall date
- September 22, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- RC Outsourcing, LLC recalls Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, R…
- Recall number
- D-0003-2026
- FDA classification
- Class II
- Brand / firm
- RC Outsourcing, LLC
- Sold / distributed
- Nationwide in the US
Why it was recalled
Lack of assurance of sterility.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436.
Get recall alerts
Free email alert whenever RC Outsourcing, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: RC Outsourcing, LLC